Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Asset ManagementConsolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Financial Services FeesIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - Fed FundsInterest Income - NetInterest Income - TotalInterest Income - Trading Account AssetsInvestment Gain (Loss)Net Income - MinorityNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeNon-Interest IncomeOperating ExpensesOther Operating ExpensesProfit After TaxProvisionsRent ExpenseResearch & DevelopmentRevenueService ChargesShares Outstanding (Diluted Average)Tax ProvisionsTax RateTax RateTrading IncomeWages, Salaries and Other
Others
Ratios

Nomura Holdings (NMR) Other Operating Expenses (2016 - 2026)

Nomura Holdings has reported Other Operating Expenses over the past 18 years, most recently at $2.8 billion for Q1 2026.

  • For Q1 2026, Other Operating Expenses rose 314.55% year-over-year to $2.8 billion; the TTM value through Mar 2026 reached $10.1 billion, up 93.12%, while the annual FY2026 figure was $9.7 billion, 86.45% up from the prior year.
  • Other Operating Expenses for Q1 2026 was $2.8 billion at Nomura Holdings, up from $2.5 billion in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $2.8 billion in Q1 2026 and troughed at -$1.3 billion in Q1 2025.
  • A 5-year average of $2.0 billion and a median of $2.1 billion in 2023 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: plummeted 158.92% in 2025 and later soared 314.55% in 2026.
  • Year by year, Other Operating Expenses stood at $2.0 billion in 2022, then fell by 0.44% to $2.0 billion in 2023, then grew by 10.41% to $2.2 billion in 2024, then rose by 13.26% to $2.5 billion in 2025, then increased by 11.0% to $2.8 billion in 2026.
  • Business Quant data shows Other Operating Expenses for NMR at $2.8 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.4 billion in Q3 2025.